Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 9,200 shares at $15.11 ($140K) on 2007-11-28, disclosed to the SEC on 2007-11-29.
Scheduled sale ($140k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.94 | 400 | $6K | 4.3% |
| 2 | $14.95 | 100 | $1K | 1.1% |
| 3 | $14.96 | 200 | $3K | 2.1% |
| 4 | $15.08 | 300 | $5K | 3.2% |
| 5 | $15.10 | 300 | $5K | 3.2% |
| 6 | $15.11 | 200 |
| $3K |
| 2.2% |
| 7 | $15.12 | 100 | $2K | 1.1% |
| 8 | $15.13 | 300 | $5K | 3.2% |
| 9 | $15.14 | 100 | $2K | 1.1% |
| 10 | $15.15 | 200 | $3K | 2.2% |
| 11 | $15.16 | 300 | $5K | 3.2% |
| 12 | $15.17 | 300 | $5K | 3.2% |
| 13 | $15.18 | 100 | $2K | 1.1% |
| 14 | $15.19 | 200 | $3K | 2.2% |
| 15 | $15.20 | 400 | $6K | 4.3% |
| 16 | $15.23 | 200 | $3K | 2.2% |
| 17 | $15.24 | 500 | $8K | 5.4% |
| 18 | $15.25 | 400 | $6K | 4.4% |
| 19 | $15.27 | 500 | $8K | 5.4% |
| 20 | $15.28 | 400 | $6K | 4.4% |
| 21 | $15.30 | 500 | $8K | 5.5% |
| 22 | $15.31 | 200 | $3K | 2.2% |
| 23 | $15.32 | 700 | $11K | 7.6% |
| 24 | $15.34 | 1,100 | $17K | 12.0% |
| 25 | $15.35 | 300 | $5K | 3.3% |
| 26 | $15.39 | 200 | $3K | 2.2% |
| 27 | $15.44 | 400 | $6K | 4.4% |
| 28 | $15.46 | 100 | $2K | 1.1% |
| 29 | $15.53 | 100 | $2K | 1.1% |
| 30 | $15.69 | 100 | $2K | 1.1% |
| Total | $15.24 avg | 9,200 | $140K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |